Frontotemporal Degeneration FTD Sequencing Consortium: Discovery, replication and validation (UG3/UH3)

Funding Opportunity RFA-NS-17-017 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to support the genetic discovery, replication and validation of disease causing mutations, risk variants and genetic modifiers which contribute to the pathophysiology, proteinopathies and clinical heterogeneity representative of the neurological syndromes that are classified under the broad spectrum of Frontotemporal Degeneration (FTD). The FTD Sequencing Consortium FOA will support whole genome sequencing, replication and functional variant validation studies of FTD case/control and family-based cohorts identified through clinical diagnosis or autopsy confirmation.
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding